Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Synaptive Medical Denmark ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2016 N/A 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   0.0% 12.0% 14.1% 16.5% 24.0% 13.3% 20.2% 20.2%   Credit score (0-100)   0 22 17 11 3 16 5 5   Credit rating   N/A BB BB BB B BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 -0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 N/A 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   0.0 86.8 58.6 -11.9 -32.6 0.0 0.0 0.0   EBITDA   0.0 86.8 58.6 -11.9 -32.6 0.0 0.0 0.0   EBIT   0.0 86.8 58.6 -11.9 -32.6 0.0 0.0 0.0   Pre-tax profit (PTP)   0.0 86.8 58.7 -12.0 -126.7 0.0 0.0 0.0   Net earnings   0.0 67.7 44.6 -15.3 -130.1 -2.6 0.0 0.0   Pre-tax profit without non-rec. items   0.0 86.8 58.7 -12.0 -127 0.0 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 N/A 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   0.0 118 162 147 16.8 14.2 -35.8 -35.8   Interest-bearing liabilities   0.0 626 68.3 293 0.0 26.5 35.8 35.8   Balance sheet total (assets)   0.0 793 430 479 91.9 83.2 0.0 0.0   Net Debt   0.0 626 68.3 293 0.0 26.5 35.8 35.8     See the entire balance sheet 1000.0 Volume  2016 N/A 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 86.8 58.6 -11.9 -32.6 0.0 0.0 0.0   Gross profit growth   0.0% 0.0% -32.5% 0.0% -174.6% 0.0% 0.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 793 430 479 92 83 0 0   Balance sheet change%   0.0% 0.0% -45.7% 11.3% -80.8% -9.4% -100.0% 0.0%   Added value   0.0 86.8 58.6 -11.9 -32.6 0.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 1.0 2.0 -1.0 -2.0 0.0 0.0 0.0   1000.0 Profitability  2016 N/A 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 100.0% 100.0% 100.0% 100.0% 0.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% 10.9% 9.6% -2.6% -11.4% 0.0% 0.0% 0.0%   ROI %   0.0% 11.7% 12.0% -3.5% -14.3% 0.0% 0.0% 0.0%   ROE %   0.0% 57.5% 31.9% -9.9% -158.9% -17.0% 0.0% 0.0%   1000.0 Solidity  2016 N/A 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Equity ratio %   0.0% 14.8% 37.7% 30.7% 18.3% 17.0% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% 721.5% 116.7% -2,465.3% 0.0% 0.0% 0.0% 0.0%   Gearing %   0.0% 532.1% 42.1% 199.4% 0.0% 186.5% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.1% 64.2% 0.0% 0.0% 0.0%   1000.0 Liquidity  2016 N/A 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Quick Ratio   0.0 1.2 1.6 1.4 1.2 1.2 0.0 0.0   Current Ratio   0.0 1.2 1.6 1.4 1.2 1.2 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2016 N/A 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 117.7 162.3 147.0 16.8 14.2 -17.9 -17.9   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 N/A 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0